Skip to main content
ILIKA PLC logo

ILIKA PLC — Investor Relations & Filings

Ticker · IGE ISIN · GB00B608Z994 LEI · 213800TMDNIE3Z8XXD26 IL Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2026-05-21 Report Publication Anno…
Country GB United Kingdom
Listing IL IGE

About ILIKA PLC

https://www.ilika.com/

Ilika PLC is a pioneer in the development and manufacturing of solid-state battery (SSB) technology. The company's portfolio is centered on two product lines: Stereax® micro-batteries and Goliath large-format batteries. Stereax® batteries are miniaturized, millimeter-scale power sources designed for applications in MedTech, such as active implanted medical devices, and for Industrial Internet of Things (IIoT) sensors. The Goliath product line is focused on developing large-format cells for the electric vehicle (EV) market. These batteries are engineered to be a safer alternative to conventional EV batteries, with the potential to deliver extended range and faster charging capabilities. Ilika's core SSB technology emphasizes safety, non-flammability, and long cycle and storage life.

Recent filings

Filing Released Lang Actions
Ilika Trading Update and Notice of Results
Report Publication Announcement Classification · 90% confidence The document is a London Stock Exchange regulatory news service (RNS) announcement titled “Ilika Trading Update and Notice of Results.” It provides a trading update for the full year 2026 and, crucially, issues notice of the timing of the audited full year results publication on 29 July 2026. It does not contain the actual financial statements or constitute an interim/annual report; rather it announces when the report will be released. This falls squarely under “Report Publication Announcement” (RPA).
2026-05-21 English
Collaboration with Brompton Bicycles
Regulatory Filings Classification · 85% confidence The document is an RNS announcement on the London Stock Exchange regarding Ilika’s collaboration with Brompton Bicycles. There is no discussion of financial results, board changes, share issuances, dividends, or other specific report types. It is a general corporate announcement published via RNS, which fits the Regulatory Filings fallback category (RNS).
2026-04-10 English
Positive Feedback on Safety of Goliath Cells
Regulatory Filings Classification · 95% confidence The document is a press release issued via the Regulatory News Service (RNS) of the London Stock Exchange. It details positive feedback from a UK defence agency regarding safety testing of the company's 'Goliath' battery cells. This is a corporate announcement regarding operational/technological progress and does not fit into specific categories like financial reports, dividend notices, or board changes. Therefore, it falls under the general regulatory announcement category.
2026-03-18 English
First Commercial Delivery to Cirtec Medical
Regulatory Filings Classification · 95% confidence The document is a press release distributed via the Regulatory News Service (RNS) of the London Stock Exchange. It announces a specific operational milestone: the completion of the first commercial delivery of Stereax electrodes to Cirtec Medical. It does not constitute a formal financial report, proxy statement, or governance filing, but rather a corporate news update regarding business operations and commercial progress. As it is a general regulatory announcement that does not fit into more specific categories like M&A or share issues, it is classified as a Regulatory Filing (RNS).
2026-03-10 English
Award of Share Options
Director's Dealing Classification · 95% confidence The document is an announcement dated 24 February 2026 from Ilika plc regarding the award of share options to executive directors and employees under the Long Term Incentive Plan (LTIP) and the EMI employee option scheme. It details the number of options granted, exercise prices, vesting conditions, and the percentage of issued share capital represented by these options. The document also includes notifications of transactions by persons discharging managerial responsibilities, consistent with insider share option grants disclosures. There is no financial statement, earnings data, or management discussion of financial results. The content is focused on share option grants and insider transactions rather than a full report or financial results. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains detailed transaction data, not just a brief announcement or a report publication notice. Therefore, the correct classification is DIRS with high confidence.
2026-02-24 English
Ilika at Yellowstone Investor Evening: Replacement
Regulatory Filings Classification · 98% confidence The document is a correction notice for a previously issued RNS (Regulatory News Service) announcement regarding an upcoming investor event. It clarifies the company name associated with the announcement. Since it is a general regulatory announcement that does not fit into specific categories like financial reports or voting results, and is distributed via the RNS platform, it is classified as a Regulatory Filing.
2026-02-19 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.